BofA Saw OpenAI as Too Risky, But Now The Bank Wants to Cash In on IPO - Bloomberg.com
Bank of America, which once viewed OpenAI as too risky, is now positioning itself to capitalize on the company's upcoming IPO.
- Bank of America previously viewed OpenAI as too risky but is now seeking to participate in its IPO.
- OpenAI's upcoming IPO could be one of the largest tech listings in years, with a potential valuation in the hundreds of billions.
- The bank's shift reflects growing institutional confidence in AI companies despite regulatory and ethical concerns.
- OpenAI's capped-profit model may have initially deterred conservative investors like Bank of America.
Bank of America initially considered OpenAI a high-risk venture, likely due to the startup's unproven business model and volatile financials. However, the bank has now reversed course, signaling its intent to participate in OpenAI's highly anticipated public offering. This shift underscores the broader industry's growing acceptance of AI companies, even those with unconventional structures like OpenAI's capped-profit model. The move also highlights the financial sector's eagerness to tap into the booming AI market, despite lingering regulatory and ethical uncertainties surrounding the technology.
The bank's decision comes as OpenAI prepares for what could be one of the largest tech IPOs in recent years, with expectations of a valuation in the hundreds of billions. Bank of America's involvement could provide OpenAI with not only capital but also enhanced credibility in the eyes of other institutional investors. Analysts suggest this pivot may reflect a broader trend of traditional finance embracing high-growth, high-risk AI ventures as the sector matures.
Source: BofA Saw OpenAI as Too Risky, But Now The Bank Wants to Cash In on IPO - Bloomberg.com. Read the full piece at the source.
Demonstrates how traditional finance is warming to high-risk, high-reward AI ventures.
Highlights a major opportunity to invest in a leading AI company ahead of its public debut.
Signals broader industry acceptance of AI despite ongoing controversies.
- capped-profit model
- A corporate structure where profits beyond a certain threshold are reinvested or donated, limiting investor returns.
China plans to let top AI firms buy limited amount of Nvidia H200 chips, the Information reports - Reuters
Exclusive: OpenAI deployment arm to acquire Northslope - Axios
UST Partners with Anthropic to Bring Claude into UST's Platforms, Engineering, and Operations and Train 20,000 UST Employees Globally - Morningstar
BusinessBlue Origin, for the first time, is expected to raise private capital
Coalition launched to advance children's rights in the age of artificial intelligence - Unicef
China to Let AI Firms Buy Nvidia H200 Chips, Information Says - Bloomberg
China will allow local AI companies to purchase Nvidia H200 chips, reversing prior restrictions on high-end AI hardware.
AI ToolsNVIDIA Nemotron Achieves Benchmark-Leading Performance With LangChain Deep Agents Harness
NVIDIA's Nemotron 3 Ultra has achieved benchmark-leading performance with the help of LangChain's Deep Agents harness, outperforming top closed models at a lower cost.
China Plans to Let Top AI Firms Buy Limited Amount of Nvidia H200 Chips - The Information
China will allow select AI companies to buy a restricted quantity of Nvidia H200 chips, according to a report from The Information.
AI ToolsA New Developer Platform for Agent-Human Collaboration
A new platform claims to let AI agents autonomously generate full software features, accelerating development cycles.
AI ToolsGoogle Deepmind adds background execution and MCP support to Gemini API managed agents
Google DeepMind is enhancing its Gemini API Managed Agents with background execution, MCP server connections, custom functions, and credential refresh capabilities.
AI helps doctors estimate your heart’s ‘age’ - KOLN | Nebraska Local News, Weather, Sports | Lincoln, NE
A new AI system helps doctors estimate a patient's heart age, potentially improving cardiovascular health outcomes. The system uses machine learning algorithms to analyze medical data.